Search
  • Site Search
  • News
  • Product
  • Zhejiang Medical Technology Development Co., Ltd.

    Common name

    Flomoxef Sodium for Injection

    Product name Flumarin®
    Common name

    Flomoxef Sodium for Injection

    Product manufacturer

    Shionogi & Co., Ltd.

    Product approval

    H20150081

    Indication

    Moderate and severe infections caused by the drug-sensitive strain:

    ○ Sepsis and infective endocarditis

    ○ Secondary infections such as trauma and surgical wounds

    ○ Pneumonia, peritonsillar abscess, empyema, bronchitis, bronchiectasis infection, and acute attack infection of chronic respiratory disease

    ○ Pyelonephritis, cystitis, prostatitis, and gonococcal urethritis

    ○ Cholecystitis and cholangitis

    ○ Peritonitis, pelvic peritonitis, and Douglas abscess

    ○ Uterine adnexitis, endometritis, pelvic inflammation, parametritis, and bartholinitis

    Specification

    1.0g (by C15H18F2N6O7S2)

    Dosage

    Standard Dose:

    For adults, the dose of Flomoxef Sodium for Injection is 1.0-2.0 g per day, twice a day (every 12 hours). For refractory or severe infections, adults can be increased to 4.0 g per day for 2 to 4 doses.

    For children, the dose of Flomoxef Sodium for Injection is 60-80mg / kg, 3-4 times per day. For premature infants and newborns, the dose is 20 mg/kg, 2-3 times per day within 3 days after birth, and 3-4 times per day after 4 days of birth.

    The dose can be increased or decreased according to age and symptoms. For premature infants, newborns and children, the dose can be increased to 150 mg/kg a day, 3-4 times per day.

    Usage: Intravenous injection or drip. The time of intravenous drip should be at least 30 minutes.

    3rd Floor, Winhealth Industrial Park, No. 272 Huancheng East Road, Xiacheng District, Hangzhou, Zhejiang, China
    BD@winhealth.Hk (overseas)
    0571-8718 6358
    Copyright ©2019 - 2024 Zhejiang Medical Technology Development Co., Ltd.